Total Funding
88
53
Total FundingSeries C raised
Growth Score 88 in past quarter
-6 pts
Heat Score 53 in past quarter
-40 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10761
Sciwind Biosciences is a drug research and development company for metabolic diseases.
- Martijn Fenaux: Senior Vice PresidentPast Role: Terns Pharmaceuticals, Vice President, Biology
- Pan Hai: CEO and Chairman
About the Company
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
